Lars Adamson

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines

Isabel Poschke, Yumeng Mao, Lars Adamson et al. · Cancer Immunology Immunotherapy · 2011 · 128 citations · Full text

Vaccination, Dendritic Cell Vaccines, Immunology +9

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma

Isabel Poschke, Tanja Lövgren, Lars Adamson et al. · Cancer Immunology Immunotherapy · 2014 · 73 citations · Full text

Vaccination, Dendritic Cell Vaccination, Cancer Immunosurveillance +10

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria

Marzia Palma, Lotta Hansson, Aniruddha Choudhury et al. · Cancer Immunology Immunotherapy · 2011 · 65 citations · Full text

Vaccination, Cancer Immunosurveillance, Immune Response Criteria +11

Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma

Anna Laurell, Maria Lönnemark, Einar Brekkan et al. · Journal for ImmunoTherapy of Cancer · 2017 · 58 citations · Full text

FXIII induced gelation of human fibrinogen — An alternative thiol enhanced, thrombin independent pathway

Birger Blombäck, Roman Procyk, Lars Adamson et al. · Thrombosis Research · 1985 · 51 citations

Thrombosis, Signal Transduction, Blood Platelet +10